Views & Analysis World Alzheimer's Day: latest research and a carer's perspec... On World Alzheimer’s Day, pharmaphorum looks at statistics, current research and the impact of dementia on families.
News Biogen drug shows potential in Alzheimer's Phase 1b trial shows aducanumab clears brain plaques.
Views & Analysis After 2015's ‘breakthrough’ year for pharma approvals, will ... Roche's MS drug is among major drugs still to come in 2016.
News Lilly pays AstraZeneca $100m as Alzheimer's drug enters phas... AstraZeneca and Eli Lilly are to continue with a pivotal phase 2/3 study of a key pipeline drug, AZD3293 for early Alzheimer's disease, after interim safety data boosted confidence in the d
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends